Newly Developed Prodrugs and Prodrugs in Development; an Insight of the Recent Years

by Anas Najjar, Abderrahman Najjar, Rafik Karaman
Published 2020-02-01

Strategies for Enhancing the Permeation of CNS-Active Drugs through the Blood-Brain Barrier: A Review

by Isra’ Zeiadeh, Anas Najjar, Rafik Karaman
Published 2018-05-01

Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years

by Hanadi Sinokrot, Tasneem Smerat, Anas Najjar, Rafik Karaman
Published 2017-10-01

Dopamine and Levodopa Prodrugs for the Treatment of Parkinson’s Disease

by Fatma Haddad, Maryam Sawalha, Yahya Khawaja, Anas Najjar, Rafik Karaman
Published 2017-12-01

Knowledge and Adherence to Medications among Palestinian Geriatrics Living with Chronic Diseases in the West Bank and East Jerusalem.

by Anas Najjar, Yazan Amro, Islam Kitaneh, Salam Abu-Sharar, Maryam Sawalha, Abrar Jamous, Muhannad Qiq, Enas Makharzeh, Bayan Subb Laban, Wafa Amro, Ahmad Amro
Published 2015-01-01